Skip to main content

Please wait ...

Peter Marks, MD, PhD

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development.  He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Dr. Marks has no disclosures.

Product Type
On Demand

Vaccine Development During the COVID-19 Pandemic

Total Credits: .75 including .75 AMA PRA Category 1 Credit(s)™

Average Rating:
Not yet rated
Peter Marks, MD, PhD
Short Description:
How did the FDA accelerate the development of the COVID vaccine?
$30.00 - Base Price

Showing 1 to 1 of 1 entries